Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saud A Sadiq

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Neurology|November 20, 2019
Stem cells in amyotrophic lateral sclerosis: Hype or hope?Saud A Sadiq, Christen Shoesmith
Journal of Neurology|November 8, 2011
Use of intrathecal clonidine in patients with multiple sclerosis or spastic paraparesisJoseph K Ho, Saud A Sadiq
Molecular Diagnosis & Therapy|August 29, 2014
Biomarkers of therapeutic response in multiple sclerosis: current statusViolaine K Harris, Saud A Sadiq
Neurodegenerative Disease Management|June 25, 2015
Stem cell therapy in multiple sclerosis: a future perspectiveViolaine K Harris, Saud A Sadiq
Journal of Neurology|December 6, 2005
Long-term intrathecal baclofen therapy in ambulatory patients with spasticitySaud A Sadiq, Gary C Wang
Molecular Diagnosis & Therapy|August 29, 2009
Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision makingViolaine K Harris, Saud A Sadiq
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 8, 2007
Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MSSaud A Sadiq, Mustapha Rammal, Gabriel Sara
Archives of Neurology|February 13, 2008
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosisSoheli A Chowdhury, Jerry Lin, Saud A Sadiq
Cytotherapy|October 12, 2016
Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosisViolaine K Harris, Tamara Vyshkina, Saud A Sadiq
Biology Open|February 6, 2023
Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defectNicolas Daviaud, Eric Chen, Tara Edwards, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Neurology|November 20, 2019
Stem cells in amyotrophic lateral sclerosis: Hype or hope?Saud A Sadiq, Christen Shoesmith
Journal of Neurology|November 8, 2011
Use of intrathecal clonidine in patients with multiple sclerosis or spastic paraparesisJoseph K Ho, Saud A Sadiq
Molecular Diagnosis & Therapy|August 29, 2014
Biomarkers of therapeutic response in multiple sclerosis: current statusViolaine K Harris, Saud A Sadiq
Neurodegenerative Disease Management|June 25, 2015
Stem cell therapy in multiple sclerosis: a future perspectiveViolaine K Harris, Saud A Sadiq
Journal of Neurology|December 6, 2005
Long-term intrathecal baclofen therapy in ambulatory patients with spasticitySaud A Sadiq, Gary C Wang
Molecular Diagnosis & Therapy|August 29, 2009
Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision makingViolaine K Harris, Saud A Sadiq
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 8, 2007
Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MSSaud A Sadiq, Mustapha Rammal, Gabriel Sara
Archives of Neurology|February 13, 2008
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosisSoheli A Chowdhury, Jerry Lin, Saud A Sadiq
Cytotherapy|October 12, 2016
Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosisViolaine K Harris, Tamara Vyshkina, Saud A Sadiq
Biology Open|February 6, 2023
Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defectNicolas Daviaud, Eric Chen, Tara Edwards, et al.
Pageof 4